WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...

A human-derived, ultra-long-acting GLP-1 injection independently researched ... has also exhibited positive results in achieving weight loss in ongoing clinical trials. The launch of this medicine ...